High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infection (Q34310410)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infection	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infection (English)

1 reference

Europe PubMed Central

1 August 2017

Leishmania major

1 reference

based on heuristic

inferred from title

Mariano Esteban

5

object named as

Mariano Esteban

1 reference

Europe PubMed Central

1 August 2017

author name string

Lucas Sánchez-Sampedro

1

1 reference

Europe PubMed Central

1 August 2017

Carmen Elena Gómez

2

1 reference

Europe PubMed Central

1 August 2017

Ernesto Mejías-Pérez

3

1 reference

Europe PubMed Central

1 August 2017

Carlos Oscar S Sorzano

4

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

8 June 2012

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

7

1 reference

Europe PubMed Central

1 August 2017

6

1 reference

Europe PubMed Central

1 August 2017

e38859

1 reference

Europe PubMed Central

1 August 2017

copyright license

Creative Commons Attribution 4.0 International

8 June 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

The development and clinical evaluation of second-generation leishmaniasis vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Leishmaniasis chemotherapy--challenges and opportunities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

CD8+ T effector memory cells protect against liver-stage malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

The magnitude of CD4(+) T-cell activation rather than TCR diversity determines the outcome of Leishmania infection in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

T-cell quality in memory and protection: implications for vaccine design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Altered ligands reveal limited plasticity in the T cell response to a pathogenic epitope

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Molecular cloning, cell localization and binding affinity to DNA replication proteins of the p36/LACK protective antigen from Leishmania infantum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Control of Leishmania major by a monoclonal alpha beta T cell repertoire.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Expression cloning of a protective Leishmania antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3371028

6 July 2018

A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038859

21 January 2018

CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038859

21 January 2018

Phenotyping of circulating CD8⁺ T cell subsets in human cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038859

21 January 2018

Determination of CD4+ and CD8+ T cells in the peripheral blood of dogs with leishmaniosis before and after prolonged allopurinol monotherapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038859

21 January 2018

Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038859

21 January 2018

The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038859

21 January 2018

Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038859

21 January 2018

Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038859

21 January 2018

Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038859

21 January 2018

IL-4 Rapidly Produced by Vβ4 Vα8 CD4+ T Cells Instructs Th2 Development and Susceptibility to Leishmania major in BALB/c Mice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038859

21 January 2018

Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038859

21 January 2018

Seventeen-colour flow cytometry: unravelling the immune system

1 reference

https://pubmed.ncbi.nlm.nih.gov/22715418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multifunctional CD4⁺ T cells in patients with American cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22715418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/22715418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TNF-alpha reverses the disease-exacerbating effect of subcutaneous immunization against murine cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22715418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to Leishmania major induced by tolerance to a single antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/22715418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb

1 reference

https://pubmed.ncbi.nlm.nih.gov/22715418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22715418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different epitopes of the LACK protein are recognized by V beta 4 V alpha 8 CD4+ T cells in H-2b and H-2d mice susceptible to Leishmania major

1 reference

https://pubmed.ncbi.nlm.nih.gov/22715418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response

1 reference

https://pubmed.ncbi.nlm.nih.gov/22715418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic resistance free plasmid DNA expressing LACK protein leads towards a protective Th1 response against Leishmania infantum infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22715418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0038859

1 reference

Europe PubMed Central

1 August 2017

2012PLoSO...738859S

0 references

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34310410&oldid=1867507416"